nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Doxepin—HRH4—stomach cancer	0.00278	0.34	CrCbGaD
Doxylamine—Amitriptyline—HRH4—stomach cancer	0.00215	0.263	CrCbGaD
Doxylamine—Somnolence—Fluorouracil—stomach cancer	0.0015	0.00175	CcSEcCtD
Doxylamine—Immune system disorder—Capecitabine—stomach cancer	0.0015	0.00175	CcSEcCtD
Doxylamine—Mediastinal disorder—Capecitabine—stomach cancer	0.0015	0.00175	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—stomach cancer	0.0015	0.00174	CcSEcCtD
Doxylamine—Erythema—Docetaxel—stomach cancer	0.0015	0.00174	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—stomach cancer	0.00148	0.00173	CcSEcCtD
Doxylamine—Decreased appetite—Fluorouracil—stomach cancer	0.00147	0.00171	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—stomach cancer	0.00147	0.00171	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—stomach cancer	0.00147	0.00171	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00146	0.0017	CcSEcCtD
Doxylamine—Feeling abnormal—Irinotecan—stomach cancer	0.00146	0.00169	CcSEcCtD
Doxylamine—Erythema—Capecitabine—stomach cancer	0.00145	0.00169	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—stomach cancer	0.00144	0.00168	CcSEcCtD
Doxylamine—Muscle spasms—Docetaxel—stomach cancer	0.00144	0.00167	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—stomach cancer	0.00142	0.00165	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00142	0.00165	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—stomach cancer	0.0014	0.00163	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.0014	0.00162	CcSEcCtD
Doxylamine—Feeling abnormal—Fluorouracil—stomach cancer	0.00139	0.00162	CcSEcCtD
Doxylamine—Muscle spasms—Capecitabine—stomach cancer	0.00139	0.00162	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—stomach cancer	0.00139	0.00161	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—stomach cancer	0.00138	0.00161	CcSEcCtD
Doxylamine—Depression—Methotrexate—stomach cancer	0.00138	0.0016	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—stomach cancer	0.00137	0.0016	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00137	0.00159	CcSEcCtD
Doxylamine—Tremor—Capecitabine—stomach cancer	0.00136	0.00158	CcSEcCtD
Doxylamine—Ill-defined disorder—Capecitabine—stomach cancer	0.00134	0.00156	CcSEcCtD
Doxylamine—Urticaria—Fluorouracil—stomach cancer	0.00134	0.00156	CcSEcCtD
Doxylamine—Leukopenia—Docetaxel—stomach cancer	0.00134	0.00156	CcSEcCtD
Doxylamine—Sweating—Methotrexate—stomach cancer	0.00132	0.00154	CcSEcCtD
Doxylamine—Palpitations—Docetaxel—stomach cancer	0.00132	0.00154	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—stomach cancer	0.00131	0.00153	CcSEcCtD
Doxylamine—Malaise—Capecitabine—stomach cancer	0.00131	0.00152	CcSEcCtD
Doxylamine—Vertigo—Capecitabine—stomach cancer	0.0013	0.00151	CcSEcCtD
Doxylamine—Hypersensitivity—Irinotecan—stomach cancer	0.0013	0.00151	CcSEcCtD
Doxylamine—Leukopenia—Capecitabine—stomach cancer	0.0013	0.00151	CcSEcCtD
Doxylamine—Convulsion—Docetaxel—stomach cancer	0.0013	0.00151	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—stomach cancer	0.00129	0.0015	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—stomach cancer	0.00129	0.0015	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00128	0.00149	CcSEcCtD
Doxylamine—Palpitations—Capecitabine—stomach cancer	0.00128	0.00149	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—stomach cancer	0.00127	0.00148	CcSEcCtD
Doxylamine—Asthenia—Irinotecan—stomach cancer	0.00127	0.00148	CcSEcCtD
Doxylamine—Hypersensitivity—Fluorouracil—stomach cancer	0.00125	0.00145	CcSEcCtD
Doxylamine—Dry mouth—Docetaxel—stomach cancer	0.00125	0.00145	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—stomach cancer	0.00124	0.00144	CcSEcCtD
Doxylamine—Sweating—Epirubicin—stomach cancer	0.00124	0.00144	CcSEcCtD
Doxylamine—Confusional state—Docetaxel—stomach cancer	0.00123	0.00143	CcSEcCtD
Doxylamine—Anxiety—Capecitabine—stomach cancer	0.00123	0.00143	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—stomach cancer	0.00122	0.00142	CcSEcCtD
Doxylamine—Anaphylactic shock—Docetaxel—stomach cancer	0.00122	0.00142	CcSEcCtD
Doxylamine—Discomfort—Capecitabine—stomach cancer	0.00122	0.00142	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—stomach cancer	0.00121	0.00141	CcSEcCtD
Doxylamine—Diarrhoea—Irinotecan—stomach cancer	0.00121	0.00141	CcSEcCtD
Doxylamine—Dry mouth—Capecitabine—stomach cancer	0.00121	0.0014	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—stomach cancer	0.0012	0.0014	CcSEcCtD
Doxylamine—Nervous system disorder—Docetaxel—stomach cancer	0.0012	0.00139	CcSEcCtD
Doxylamine—Pruritus—Fluorouracil—stomach cancer	0.0012	0.00139	CcSEcCtD
Doxylamine—Thrombocytopenia—Docetaxel—stomach cancer	0.0012	0.00139	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—stomach cancer	0.00119	0.00139	CcSEcCtD
Doxylamine—Confusional state—Capecitabine—stomach cancer	0.00119	0.00139	CcSEcCtD
Doxylamine—Tachycardia—Docetaxel—stomach cancer	0.00119	0.00139	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00118	0.00138	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—stomach cancer	0.00118	0.00137	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—stomach cancer	0.00117	0.00136	CcSEcCtD
Doxylamine—Dizziness—Irinotecan—stomach cancer	0.00117	0.00136	CcSEcCtD
Doxylamine—Anorexia—Docetaxel—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Nervous system disorder—Capecitabine—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Diarrhoea—Fluorouracil—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Thrombocytopenia—Capecitabine—stomach cancer	0.00116	0.00135	CcSEcCtD
Doxylamine—Tachycardia—Capecitabine—stomach cancer	0.00115	0.00134	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—stomach cancer	0.00115	0.00134	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—stomach cancer	0.00115	0.00133	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—stomach cancer	0.00114	0.00133	CcSEcCtD
Doxylamine—Hyperhidrosis—Capecitabine—stomach cancer	0.00114	0.00133	CcSEcCtD
Doxylamine—Hypotension—Docetaxel—stomach cancer	0.00114	0.00133	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—stomach cancer	0.00114	0.00132	CcSEcCtD
Doxylamine—Anorexia—Capecitabine—stomach cancer	0.00113	0.00131	CcSEcCtD
Doxylamine—Vomiting—Irinotecan—stomach cancer	0.00112	0.00131	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—stomach cancer	0.00112	0.0013	CcSEcCtD
Doxylamine—Dizziness—Fluorouracil—stomach cancer	0.00112	0.0013	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—stomach cancer	0.00112	0.0013	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—stomach cancer	0.00111	0.0013	CcSEcCtD
Doxylamine—Rash—Irinotecan—stomach cancer	0.00111	0.0013	CcSEcCtD
Doxylamine—Dermatitis—Irinotecan—stomach cancer	0.00111	0.0013	CcSEcCtD
Doxylamine—Hypotension—Capecitabine—stomach cancer	0.0011	0.00129	CcSEcCtD
Doxylamine—Insomnia—Docetaxel—stomach cancer	0.0011	0.00129	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—stomach cancer	0.0011	0.00128	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—stomach cancer	0.00109	0.00127	CcSEcCtD
Doxylamine—Dyspnoea—Docetaxel—stomach cancer	0.00109	0.00127	CcSEcCtD
Doxylamine—Somnolence—Docetaxel—stomach cancer	0.00109	0.00126	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—stomach cancer	0.00108	0.00126	CcSEcCtD
Doxylamine—Erythema—Methotrexate—stomach cancer	0.00108	0.00126	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—stomach cancer	0.00108	0.00125	CcSEcCtD
Doxylamine—Flushing—Epirubicin—stomach cancer	0.00108	0.00125	CcSEcCtD
Doxylamine—Vomiting—Fluorouracil—stomach cancer	0.00108	0.00125	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—stomach cancer	0.00107	0.00125	CcSEcCtD
Doxylamine—Insomnia—Capecitabine—stomach cancer	0.00107	0.00124	CcSEcCtD
Doxylamine—Rash—Fluorouracil—stomach cancer	0.00107	0.00124	CcSEcCtD
Doxylamine—Dermatitis—Fluorouracil—stomach cancer	0.00107	0.00124	CcSEcCtD
Doxylamine—Decreased appetite—Docetaxel—stomach cancer	0.00106	0.00124	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.00106	0.00123	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00105	0.00123	CcSEcCtD
Doxylamine—Dyspnoea—Capecitabine—stomach cancer	0.00105	0.00123	CcSEcCtD
Doxylamine—Fatigue—Docetaxel—stomach cancer	0.00105	0.00123	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—stomach cancer	0.00105	0.00122	CcSEcCtD
Doxylamine—Nausea—Irinotecan—stomach cancer	0.00105	0.00122	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—stomach cancer	0.00105	0.00122	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—stomach cancer	0.00104	0.00122	CcSEcCtD
Doxylamine—Constipation—Docetaxel—stomach cancer	0.00104	0.00122	CcSEcCtD
Doxylamine—Decreased appetite—Capecitabine—stomach cancer	0.00103	0.0012	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00102	0.00119	CcSEcCtD
Doxylamine—Fatigue—Capecitabine—stomach cancer	0.00102	0.00119	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—stomach cancer	0.00101	0.00118	CcSEcCtD
Doxylamine—Constipation—Capecitabine—stomach cancer	0.00101	0.00118	CcSEcCtD
Doxylamine—Erythema—Epirubicin—stomach cancer	0.00101	0.00117	CcSEcCtD
Doxylamine—Feeling abnormal—Docetaxel—stomach cancer	0.00101	0.00117	CcSEcCtD
Doxylamine—Nausea—Fluorouracil—stomach cancer	0.001	0.00117	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—stomach cancer	0.001	0.00117	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—stomach cancer	0.001	0.00116	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—stomach cancer	0.000995	0.00116	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—stomach cancer	0.000995	0.00116	CcSEcCtD
Doxylamine—Feeling abnormal—Capecitabine—stomach cancer	0.000974	0.00113	CcSEcCtD
Doxylamine—Malaise—Methotrexate—stomach cancer	0.000972	0.00113	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—stomach cancer	0.00097	0.00113	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—stomach cancer	0.000969	0.00113	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—stomach cancer	0.000969	0.00113	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000966	0.00113	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—stomach cancer	0.000965	0.00112	CcSEcCtD
Doxylamine—Urticaria—Capecitabine—stomach cancer	0.000939	0.00109	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—stomach cancer	0.000936	0.00109	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—stomach cancer	0.000934	0.00109	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—stomach cancer	0.000933	0.00109	CcSEcCtD
Doxylamine—Tamoxifen—CYP2A6—stomach cancer	0.000928	0.113	CrCbGaD
Doxylamine—Agitation—Epirubicin—stomach cancer	0.000927	0.00108	CcSEcCtD
Doxylamine—Malaise—Epirubicin—stomach cancer	0.00091	0.00106	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—stomach cancer	0.000907	0.00106	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—stomach cancer	0.000906	0.00106	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—stomach cancer	0.000903	0.00105	CcSEcCtD
Doxylamine—Hypersensitivity—Docetaxel—stomach cancer	0.000899	0.00105	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—stomach cancer	0.000897	0.00104	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—stomach cancer	0.000892	0.00104	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—stomach cancer	0.000887	0.00103	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—stomach cancer	0.00088	0.00102	CcSEcCtD
Doxylamine—Asthenia—Docetaxel—stomach cancer	0.000876	0.00102	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—stomach cancer	0.000874	0.00102	CcSEcCtD
Doxylamine—Hypersensitivity—Capecitabine—stomach cancer	0.000871	0.00101	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000866	0.00101	CcSEcCtD
Doxylamine—Pruritus—Docetaxel—stomach cancer	0.000864	0.00101	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—stomach cancer	0.000863	0.001	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000861	0.001	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—stomach cancer	0.000858	0.000999	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—stomach cancer	0.000856	0.000996	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—stomach cancer	0.000851	0.00099	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—stomach cancer	0.000849	0.000988	CcSEcCtD
Doxylamine—Asthenia—Capecitabine—stomach cancer	0.000848	0.000987	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—stomach cancer	0.000842	0.00098	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—stomach cancer	0.00084	0.000978	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—stomach cancer	0.000839	0.000976	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—stomach cancer	0.000839	0.000976	CcSEcCtD
Doxylamine—Pruritus—Capecitabine—stomach cancer	0.000836	0.000973	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—stomach cancer	0.000836	0.000973	CcSEcCtD
Doxylamine—Diarrhoea—Docetaxel—stomach cancer	0.000835	0.000972	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—stomach cancer	0.00083	0.000967	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—stomach cancer	0.000825	0.00096	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—stomach cancer	0.000823	0.000959	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—stomach cancer	0.000822	0.000957	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—stomach cancer	0.000809	0.000942	CcSEcCtD
Doxylamine—Diarrhoea—Capecitabine—stomach cancer	0.000809	0.000941	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—stomach cancer	0.000807	0.00094	CcSEcCtD
Doxylamine—Dizziness—Docetaxel—stomach cancer	0.000807	0.00094	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000806	0.000939	CcSEcCtD
Doxylamine—Doxepin—HTR1A—stomach cancer	0.000804	0.0982	CrCbGaD
Doxylamine—Tachycardia—Epirubicin—stomach cancer	0.000804	0.000936	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—stomach cancer	0.000796	0.000927	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—stomach cancer	0.000796	0.000926	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—stomach cancer	0.000792	0.000922	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—stomach cancer	0.000785	0.000914	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—stomach cancer	0.000785	0.000914	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—stomach cancer	0.000784	0.000913	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—stomach cancer	0.000782	0.000911	CcSEcCtD
Doxylamine—Dizziness—Capecitabine—stomach cancer	0.000782	0.00091	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—stomach cancer	0.000777	0.000905	CcSEcCtD
Doxylamine—Vomiting—Docetaxel—stomach cancer	0.000776	0.000904	CcSEcCtD
Doxylamine—Rash—Docetaxel—stomach cancer	0.00077	0.000896	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—stomach cancer	0.000769	0.000896	CcSEcCtD
Doxylamine—Dermatitis—Docetaxel—stomach cancer	0.000769	0.000895	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—stomach cancer	0.000768	0.000894	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—stomach cancer	0.000765	0.00089	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000762	0.000887	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00076	0.000884	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—stomach cancer	0.000759	0.000883	CcSEcCtD
Doxylamine—Vomiting—Capecitabine—stomach cancer	0.000751	0.000875	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—stomach cancer	0.000747	0.00087	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000746	0.000868	CcSEcCtD
Doxylamine—Rash—Capecitabine—stomach cancer	0.000745	0.000868	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—stomach cancer	0.000745	0.000867	CcSEcCtD
Doxylamine—Dermatitis—Capecitabine—stomach cancer	0.000744	0.000867	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—stomach cancer	0.000744	0.000866	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000736	0.000857	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—stomach cancer	0.000734	0.000855	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—stomach cancer	0.000732	0.000852	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—stomach cancer	0.000726	0.000845	CcSEcCtD
Doxylamine—Nausea—Docetaxel—stomach cancer	0.000725	0.000844	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—stomach cancer	0.000725	0.000844	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—stomach cancer	0.000716	0.000833	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—stomach cancer	0.000712	0.000829	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000711	0.000828	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—stomach cancer	0.00071	0.000826	CcSEcCtD
Doxylamine—Constipation—Epirubicin—stomach cancer	0.000704	0.00082	CcSEcCtD
Doxylamine—Nausea—Capecitabine—stomach cancer	0.000702	0.000817	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—stomach cancer	0.000699	0.000814	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—stomach cancer	0.000689	0.000802	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—stomach cancer	0.000679	0.000791	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—stomach cancer	0.000678	0.00079	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—stomach cancer	0.000677	0.000788	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—stomach cancer	0.000662	0.000771	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000658	0.000766	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—stomach cancer	0.000657	0.000765	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—stomach cancer	0.000654	0.000761	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—stomach cancer	0.000651	0.000758	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—stomach cancer	0.000648	0.000755	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—stomach cancer	0.000631	0.000735	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000628	0.000731	CcSEcCtD
Doxylamine—Imipramine—HTR1A—stomach cancer	0.000625	0.0764	CrCbGaD
Doxylamine—Pruritus—Methotrexate—stomach cancer	0.000622	0.000725	CcSEcCtD
Doxylamine—Amitriptyline—HTR1A—stomach cancer	0.000622	0.0759	CrCbGaD
Doxylamine—Hypersensitivity—Epirubicin—stomach cancer	0.000607	0.000706	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—stomach cancer	0.000605	0.000705	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—stomach cancer	0.000602	0.000701	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—stomach cancer	0.000591	0.000688	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—stomach cancer	0.000583	0.000678	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—stomach cancer	0.000582	0.000677	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—stomach cancer	0.000563	0.000656	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—stomach cancer	0.000561	0.000653	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—stomach cancer	0.000559	0.000651	CcSEcCtD
Doxylamine—Rash—Methotrexate—stomach cancer	0.000555	0.000646	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—stomach cancer	0.000554	0.000645	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—stomach cancer	0.000547	0.000636	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—stomach cancer	0.000544	0.000634	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—stomach cancer	0.000539	0.000627	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—stomach cancer	0.000523	0.000609	CcSEcCtD
Doxylamine—Nausea—Methotrexate—stomach cancer	0.000523	0.000608	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—stomach cancer	0.000521	0.000607	CcSEcCtD
Doxylamine—Rash—Epirubicin—stomach cancer	0.000519	0.000604	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—stomach cancer	0.000519	0.000604	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—stomach cancer	0.000504	0.000587	CcSEcCtD
Doxylamine—Nausea—Epirubicin—stomach cancer	0.000489	0.000569	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—stomach cancer	0.000484	0.000564	CcSEcCtD
Doxylamine—Rash—Doxorubicin—stomach cancer	0.00048	0.000559	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—stomach cancer	0.00048	0.000559	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—stomach cancer	0.000453	0.000527	CcSEcCtD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000326	0.00245	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000325	0.00245	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—APC—stomach cancer	0.000313	0.00235	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000308	0.00232	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000307	0.00231	CbGpPWpGaD
Doxylamine—Amitriptyline—ALB—stomach cancer	0.000279	0.0341	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—AGTR2—stomach cancer	0.000276	0.00208	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—AGTR2—stomach cancer	0.000275	0.00207	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—F2R—stomach cancer	0.000273	0.00205	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—F2R—stomach cancer	0.000272	0.00205	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HRH4—stomach cancer	0.000268	0.00202	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HRH4—stomach cancer	0.000267	0.00201	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR1A—stomach cancer	0.000265	0.002	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1A—stomach cancer	0.000265	0.00199	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000264	0.00199	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000263	0.00198	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—RHOA—stomach cancer	0.000262	0.00197	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—CDK4—stomach cancer	0.000262	0.00197	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ANXA1—stomach cancer	0.000256	0.00193	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ANXA1—stomach cancer	0.000256	0.00192	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRB1—stomach cancer	0.000248	0.00187	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRB1—stomach cancer	0.000247	0.00186	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HRH4—stomach cancer	0.000244	0.00183	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000244	0.00183	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HRH4—stomach cancer	0.000243	0.00183	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000243	0.00183	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—KISS1—stomach cancer	0.000239	0.0018	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—KISS1—stomach cancer	0.000238	0.00179	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—PPARG—stomach cancer	0.000238	0.00179	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000217	0.00164	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—KISS1—stomach cancer	0.000217	0.00163	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000217	0.00163	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—KISS1—stomach cancer	0.000216	0.00163	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—SERPINE1—stomach cancer	0.000214	0.00161	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GAST—stomach cancer	0.000206	0.00155	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—RGS2—stomach cancer	0.000206	0.00155	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—RGS2—stomach cancer	0.000205	0.00154	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GAST—stomach cancer	0.000205	0.00154	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRB2—stomach cancer	0.000201	0.00151	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRB2—stomach cancer	0.000201	0.00151	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GLI3—stomach cancer	0.000199	0.0015	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KISS1R—stomach cancer	0.000199	0.0015	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KISS1R—stomach cancer	0.000198	0.00149	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GLI3—stomach cancer	0.000198	0.00149	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RBP1—stomach cancer	0.00019	0.00143	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RBP1—stomach cancer	0.000189	0.00142	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GAST—stomach cancer	0.000187	0.00141	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—RGS2—stomach cancer	0.000187	0.00141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RGS2—stomach cancer	0.000186	0.0014	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GAST—stomach cancer	0.000186	0.0014	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—stomach cancer	0.000177	0.00133	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—JUN—stomach cancer	0.000169	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—stomach cancer	0.000168	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—stomach cancer	0.000168	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—MAPK8—stomach cancer	0.000159	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—KRAS—stomach cancer	0.000159	0.0012	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AGTR2—stomach cancer	0.000156	0.00117	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AGTR2—stomach cancer	0.000155	0.00117	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—WWOX—stomach cancer	0.000155	0.00117	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—WWOX—stomach cancer	0.000154	0.00116	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—F2R—stomach cancer	0.000154	0.00116	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—F2R—stomach cancer	0.000154	0.00116	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1A—stomach cancer	0.00015	0.00113	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1A—stomach cancer	0.00015	0.00113	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	0.000146	0.0011	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ANXA1—stomach cancer	0.000145	0.00109	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ANXA1—stomach cancer	0.000144	0.00109	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—WIF1—stomach cancer	0.000144	0.00108	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HRH4—stomach cancer	0.000144	0.00108	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—WIF1—stomach cancer	0.000143	0.00108	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HRH4—stomach cancer	0.000143	0.00108	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AGTR2—stomach cancer	0.000142	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AGTR2—stomach cancer	0.000141	0.00106	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRB1—stomach cancer	0.00014	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—F2R—stomach cancer	0.00014	0.00105	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRB1—stomach cancer	0.00014	0.00105	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—F2R—stomach cancer	0.000139	0.00105	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1A—stomach cancer	0.000136	0.00103	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1A—stomach cancer	0.000136	0.00102	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKAB1—stomach cancer	0.000133	0.001	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKAB1—stomach cancer	0.000132	0.000996	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000132	0.000996	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000132	0.000993	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ANXA1—stomach cancer	0.000132	0.00099	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ANXA1—stomach cancer	0.000131	0.000987	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RNF43—stomach cancer	0.000128	0.000965	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KISS1—stomach cancer	0.000128	0.000965	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RNF43—stomach cancer	0.000128	0.000962	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KISS1—stomach cancer	0.000128	0.000962	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000128	0.00096	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRB1—stomach cancer	0.000127	0.000959	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000127	0.000957	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRB1—stomach cancer	0.000127	0.000956	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000126	0.000948	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000126	0.000948	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000126	0.000945	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000126	0.000945	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000122	0.00092	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000122	0.000917	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000119	0.000895	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000119	0.000893	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FST—stomach cancer	0.000114	0.000861	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FST—stomach cancer	0.000114	0.000858	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRB2—stomach cancer	0.000114	0.000856	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRB2—stomach cancer	0.000113	0.000853	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HBEGF—stomach cancer	0.000112	0.000842	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HBEGF—stomach cancer	0.000112	0.000839	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—TP53—stomach cancer	0.000111	0.000837	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RGS2—stomach cancer	0.00011	0.00083	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GAST—stomach cancer	0.00011	0.00083	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RGS2—stomach cancer	0.00011	0.000828	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GAST—stomach cancer	0.00011	0.000828	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000109	0.000823	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000109	0.00082	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGG—stomach cancer	0.000105	0.000787	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGG—stomach cancer	0.000104	0.000785	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRB2—stomach cancer	0.000103	0.000777	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRB2—stomach cancer	0.000103	0.000775	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—IL6—stomach cancer	0.000102	0.000766	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000101	0.000761	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000101	0.000761	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000101	0.000759	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000101	0.000759	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKAA1—stomach cancer	0.000101	0.000758	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKAA1—stomach cancer	0.0001	0.000755	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RBP4—stomach cancer	9.72e-05	0.000732	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CXCL8—stomach cancer	9.72e-05	0.000731	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RBP4—stomach cancer	9.69e-05	0.000729	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CXCL8—stomach cancer	9.68e-05	0.000729	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	9.68e-05	0.000728	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	9.65e-05	0.000726	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HSPB1—stomach cancer	8.36e-05	0.000629	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGTR2—stomach cancer	8.36e-05	0.000629	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HSPB1—stomach cancer	8.33e-05	0.000627	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGTR2—stomach cancer	8.33e-05	0.000627	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BMP2—stomach cancer	8.27e-05	0.000622	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—F2R—stomach cancer	8.27e-05	0.000622	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—F2R—stomach cancer	8.24e-05	0.00062	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BMP2—stomach cancer	8.24e-05	0.00062	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	8.13e-05	0.000612	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	8.11e-05	0.00061	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1A—stomach cancer	8.05e-05	0.000606	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1A—stomach cancer	8.02e-05	0.000604	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	7.79e-05	0.000586	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ANXA1—stomach cancer	7.77e-05	0.000585	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	7.77e-05	0.000585	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ANXA1—stomach cancer	7.75e-05	0.000583	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB1—stomach cancer	7.53e-05	0.000567	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB1—stomach cancer	7.5e-05	0.000565	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RPS6—stomach cancer	7.19e-05	0.000541	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RPS6—stomach cancer	7.17e-05	0.000539	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	7.08e-05	0.000533	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	7.05e-05	0.000531	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	7.05e-05	0.00053	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	7.02e-05	0.000529	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HBEGF—stomach cancer	6.61e-05	0.000497	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HBEGF—stomach cancer	6.59e-05	0.000496	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6R—stomach cancer	6.29e-05	0.000473	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6R—stomach cancer	6.27e-05	0.000472	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	6.25e-05	0.000471	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	6.23e-05	0.000469	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB2—stomach cancer	6.1e-05	0.000459	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB2—stomach cancer	6.08e-05	0.000458	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	5.98e-05	0.00045	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	5.96e-05	0.000448	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—RHOA—stomach cancer	5.68e-05	0.000427	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RHOA—stomach cancer	5.66e-05	0.000426	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SMAD4—stomach cancer	5.55e-05	0.000418	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SMAD4—stomach cancer	5.53e-05	0.000416	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	5.49e-05	0.000413	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.47e-05	0.000412	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FYN—stomach cancer	5.27e-05	0.000397	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FYN—stomach cancer	5.25e-05	0.000395	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	4.99e-05	0.000375	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	4.97e-05	0.000374	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGFR2—stomach cancer	4.95e-05	0.000372	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGFR2—stomach cancer	4.93e-05	0.000371	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IRS2—stomach cancer	4.53e-05	0.000341	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IRS2—stomach cancer	4.51e-05	0.00034	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CAV1—stomach cancer	4.39e-05	0.000331	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOA1—stomach cancer	4.38e-05	0.00033	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CAV1—stomach cancer	4.38e-05	0.000329	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOA1—stomach cancer	4.37e-05	0.000329	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCB—stomach cancer	4.18e-05	0.000315	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCB—stomach cancer	4.17e-05	0.000314	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6ST—stomach cancer	4.16e-05	0.000313	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6ST—stomach cancer	4.15e-05	0.000312	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APC—stomach cancer	4e-05	0.000301	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APC—stomach cancer	3.99e-05	0.0003	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	3.83e-05	0.000288	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	3.82e-05	0.000287	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6R—stomach cancer	3.71e-05	0.00028	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6R—stomach cancer	3.7e-05	0.000279	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	3.65e-05	0.000274	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EGFR—stomach cancer	3.64e-05	0.000274	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	3.63e-05	0.000273	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EGFR—stomach cancer	3.63e-05	0.000273	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	3.48e-05	0.000262	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	3.48e-05	0.000262	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.47e-05	0.000261	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	3.47e-05	0.000261	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—KRAS—stomach cancer	3.44e-05	0.000259	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—KRAS—stomach cancer	3.43e-05	0.000258	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RHOA—stomach cancer	3.36e-05	0.000253	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.34e-05	0.000252	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOS3—stomach cancer	3.32e-05	0.00025	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.31e-05	0.000249	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	3.16e-05	0.000238	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.15e-05	0.000237	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ERBB2—stomach cancer	3.11e-05	0.000234	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	3.1e-05	0.000233	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL8—stomach cancer	2.95e-05	0.000222	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.94e-05	0.000221	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HRAS—stomach cancer	2.93e-05	0.00022	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.92e-05	0.00022	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	2.88e-05	0.000216	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.87e-05	0.000216	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—stomach cancer	2.8e-05	0.000211	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.79e-05	0.00021	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCND1—stomach cancer	2.74e-05	0.000207	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JUN—stomach cancer	2.74e-05	0.000206	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.74e-05	0.000206	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JUN—stomach cancer	2.73e-05	0.000205	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP9—stomach cancer	2.66e-05	0.000201	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.66e-05	0.0002	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	2.65e-05	0.0002	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.65e-05	0.000199	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK8—stomach cancer	2.59e-05	0.000195	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.58e-05	0.000194	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.39e-05	0.00018	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.38e-05	0.000179	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STAT3—stomach cancer	2.37e-05	0.000178	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.36e-05	0.000178	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.26e-05	0.00017	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.26e-05	0.00017	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MYC—stomach cancer	2.2e-05	0.000166	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MYC—stomach cancer	2.19e-05	0.000165	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.15e-05	0.000162	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EGFR—stomach cancer	2.15e-05	0.000162	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.15e-05	0.000162	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.15e-05	0.000162	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KRAS—stomach cancer	2.03e-05	0.000153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KRAS—stomach cancer	2.03e-05	0.000153	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	1.87e-05	0.000141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.86e-05	0.00014	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TP53—stomach cancer	1.81e-05	0.000136	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TP53—stomach cancer	1.8e-05	0.000136	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HRAS—stomach cancer	1.73e-05	0.00013	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.72e-05	0.00013	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—stomach cancer	1.65e-05	0.000125	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—stomach cancer	1.65e-05	0.000124	CbGpPWpGaD
